Stockscreener 앱 받기
2.60
7.14%
-0.20
전일 마감가:
$2.80
열려 있는:
$2.66
하루 거래량:
26,060
Relative Volume:
0.84
시가총액:
$22.40M
수익:
-
순이익/손실:
$-20.74M
주가수익비율:
-1.0359
EPS:
-2.51
순현금흐름:
$-18.90M
1주 성능:
+4.42%
1개월 성능:
-7.14%
6개월 성능:
+0.00%
1년 성능:
-15.09%
1일 변동 폭
$2.5547
$2.7809
1주일 범위
$2.47
$3.0799
52주 변동 폭
$1.87
$4.20
Lisata Therapeutics Inc Stock (LSTA) Company Profile
명칭
Lisata Therapeutics Inc
전화
908-229-2590
주소
110 ALLEN ROAD, BASKING RIDGE
LSTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LSTA
Lisata Therapeutics Inc
|
2.60 | 25.45M | 0 | -20.74M | -18.90M | -2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Lisata Therapeutics Inc 주식(LSTA)의 최신 뉴스
Lisata extends cash runway into Q4 2026 while advancing certepetide development milestones - MSN
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q2 2025 Earnings Call Transcript - Insider Monkey
Lisata Therapeutics Q2 2025 Earnings Preview - MSN
Earnings call transcript: Lisata Therapeutics Q2 2025 beats EPS forecast - Investing.com
Lisata Therapeutics Reports Q2 2025 Financial Results - TipRanks
Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections - AInvest
Lisata Therapeutics Inc (LSTA) Q2 2025 Earnings Call Highlights: - GuruFocus
Lisata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Lisata Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Lisata Therapeutics Reports Strong Q2 2025 Financials - TipRanks
Lisata Therapeutics advances lead cancer drug, expects key trial results by year-end - Proactive financial news
Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Lisata Therapeutics LSTA 2025Q2 Earnings Preview Upside Potential on Robust Revenue Growth - AInvest
Lisata Therapeutics Inc. Shows Risk Reward Favoring UpsideFree Stock Market Trend Analysis - beatles.ru
Quant Models Detect Momentum Reversal in Lisata Therapeutics Inc.Low Risk Picks for Daily Trading Released - beatles.ru
Is Lisata Therapeutics Inc. a growth stock or a value stockFree Trend-Following Techniques - Jammu Links News
Is Lisata Therapeutics Inc. a good long term investmentUnlock exclusive stock market forecasts - Jammu Links News
What is Lisata Therapeutics Inc. company’s growth strategyGet timely alerts on market opportunities - Jammu Links News
What are Lisata Therapeutics Inc. company’s key revenue driversAchieve superior returns with professional insights - Jammu Links News
What are the technical indicators suggesting about Lisata Therapeutics Inc.Maximize your gains with professional insights - Jammu Links News
Should I hold or sell Lisata Therapeutics Inc. stock in 2025Maximize your returns with portfolio optimization - Jammu Links News
Why is Lisata Therapeutics Inc. stock attracting strong analyst attentionGet daily updates on promising stocks - Jammu Links News
What is the risk reward ratio of investing in Lisata Therapeutics Inc. stockCapitalize on fast-growing stocks today - Jammu Links News
What makes Lisata Therapeutics Inc. stock price move sharplyGet expert advice on portfolio optimization - Jammu Links News
How many analysts rate Lisata Therapeutics Inc. as a “Buy”Build wealth steadily with smart stock selection - Jammu Links News
Is Lisata Therapeutics Inc. stock overvalued or undervaluedFree Smart Trading Workshop - Jammu Links News
What institutional investors are buying Lisata Therapeutics Inc. stockBreakout portfolio performance - Jammu Links News
Does Lisata Therapeutics Inc. stock perform well during market downturnsInvest in stocks with strong fundamentals - Jammu Links News
Using data models to predict Lisata Therapeutics Inc. stock movementShort Term Profit Strategy with Entry Cues - Newser
Why Lisata Therapeutics Inc. stock attracts strong analyst attentionTrading Volume Anomaly Summary and Insight - Newser
Is Lisata Therapeutics Inc. stock ready for a breakoutFree Short Term High Yield Stock Tips - Newser
Using R and stats models for Lisata Therapeutics Inc. forecastingPredictable Return Plan with Entry Guidance - Newser
Lisata Therapeutics Inc. stock prediction for this weekFree Fundamental + Technical Hybrid Stock Tips - Newser
Backtesting results for Lisata Therapeutics Inc. trading strategies3-Day Market Movement Forecast Analysis - Newser
Tools to assess Lisata Therapeutics Inc.’s risk profileShort Term Opportunity Finder with Tools - Newser
Lisata Therapeutics to Report Second Quarter 2025 Financial - GlobeNewswire
How volatile is Lisata Therapeutics Inc. stock compared to the marketPost Market Planner For Smart Trading - Jammu Links News
Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025 - The Manila Times
Lisata Therapeutics Earnings: Clinical-Stage Pharma Giant Sets Q2 2025 Financial Review - Stock Titan
Combining machine learning predictions for Lisata Therapeutics Inc.Free Watchlist for Smart Swing Trading - Newser
How Lisata Therapeutics Inc. stock performs during market volatilityWeekly Trend Watch with Market Signals - Newser
Is Lisata Therapeutics Inc. Stock a Good Fit for Conservative InvestorsWeekly Stock Opportunity Radar Scanner Activated - metal.it
Lisata Therapeutics Inc (LSTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):